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Abstract
Introduction: Neural stem cells (NSCs) reside along the ventricular axis of the
mammalian brain. They divide infrequently to maintain themselves and the
down-stream progenitors. Due to the quiescent property of NSCs, attempts to
deplete these cells using antimitotic agents such as cytosine b-Aarabinofura-
noside (Ara-C) have not been successful. We hypothesized that implementing
infusion gaps in Ara-C kill paradigms would recruit the quiescent NSCs and
subsequently eliminate them from their niches in the subventricular zone
(SVZ). Methods: We infused the right lateral ventricle of adult mice brain with
2% Ara-C using four different paradigms—1: one week; 2: two weeks; 3, 4: two
weeks with an infusion gap of 6 and 12 h on day 7. Neurosphere assay (NSA),
neural colony-forming cell assay (N-CFCA) and immunofluorescent staining
were used to assess depletion of NSCs from the SVZ. Results: Neurosphere for-
mation dramatically decreased in all paradigms immediately after Ara-C infu-
sion. Reduction in neurosphere formation was more pronounced in the 3rd
and 4th paradigms. Interestingly 1 week after Ara-C infusion, neurosphere for-
mation recovered toward control values implying the presence of NSCs in the
harvested SVZ tissue. Unexpectedly, N-CFCA in the 3rd paradigm, as one of
the most effective paradigms, did not result in formation of NSC-derived colo-
nies (colonies >2 mm) even from SVZs harvested 1 week after completion of
Ara-C infusion. However, formation of big colonies with serial passaging capa-
bility, again confirmed the presence of NSCs. Conclusions: Overall, these data
suggest Ara-C kill paradigms with infusion gaps deplete NSCs in the SVZ more
efficiently but the niches would repopulate even after the most vigorous kill
paradigm used in this study.
Introduction
Neural stem cells (NSCs) are residing in niches along the
ventricular neuraxis of the mammalian nervous system
(Craig et al. 1996; Golmohammadi et al. 2008; Mirzadeh
et al. 2008; Shen et al. 2008). They are capable of self-
renewal, prolonged cell division, and generating a large
number of progeny (Reynolds and Weiss 1992). Previous
studies have demonstrated three main cell types in the
adult subventricular zone (SVZ) stem cell niche; namely,
type B NSCs (glial fibrillary acidic protein (GFAP+)
expressing cells) that give rise to type C transit amplifying
cells (GFAP/Dlx2+), which in turn generate type A
neuroblast (GFAP/Dlx2+/doublecortin (DCX)+) cells
(Doetsch et al. 1999b; Riquelme et al. 2008; Chojnacki
et al. 2009) migrating through a channel of interwoven
astrocytes, the rostral migratory stream (RMS), to the
olfactory bulb. The SVZ niche is separated from the cere-
brospinal fluid (CSF) of the ventricles via a thin layer of
multiciliated ependymal cells. Ependymal cells not only
act as a physical barrier and a sensor of CSF components
through coupling with SVZ astrocytes but also secrete
proneurogenic factors such as Noggin to create a favor-
able neurogenic environment (Lim et al. 2000). Some of
the type B cells have long processes intercalating between
adjacent ependymal cells to assess the ventricular area
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(Doetsch et al. 1999a; Silva-Vargas et al. 2013; Codega
et al. 2014). In contact with the ventricle, these processes
express a primary cilium that might function for trans-
duction of signals in the CSF. Away from the ventricular
side, the niche is related to a dense network of vessels
with laminin-rich basal lamina (Mercier et al. 2002; Silva-
Vargas et al. 2013). Cellular states of quiescence, prolifer-
ation, differentiation in SVZ niche is finely tuned via
multiple mechanisms including the inherent genetic state
of the niche cells and the signals arriving from the
microenvironment including the CSF, niche blood vessels,
surrounding neural networks via axonal terminals and
interaction of niche resident cells (Doetsch et al. 1997;
Silva-Vargas et al. 2013). Interestingly, among the cell
content of the stem cell niche in the SVZ, the NSCs (type
B) are quiescent and divide infrequently to maintain the
pool of stem cells and the down-stream progenitors
through symmetric or asymmetric divisions (Morshead
et al. 1994; Riquelme et al. 2008). This characteristic
reduces the possibility of mutations in the genome of
long-lived stem cells (Reya et al. 2001). Experiments on
in vivo activation and/or depletion of the NSCs and their
progeny have largely increased our understanding of
niche microenvironment, cellular diversity, and behavior.
Antimitotic drug cytosine b-Aarabinofuranoside (Ara-C)
can actively eliminate dividing cells. Researchers used
Ara-C treatment to eliminate neural stem and progenitor
cells from the SVZ stem cell niches but these attempt
were not successful to eliminate the entire pool of NSCs
mainly due to their quiescent property at the time of
antimitotic drug infusion and also because of applying
short term (3–7 days) continuous Ara-C infusion para-
digms (Morshead et al. 1994; Pastrana et al. 2009; Codega
et al. 2014; Sachewsky et al. 2014). In a study by Fiona
Doetsch et al. after AraC infusion for 6 days and examin-
ing the whole-mount preparation of the SVZ at 0 and
12 h post infusion, they could only see activated NSCs
expressing minichromosome maintenance 2 (MCM2), a
marker indicating the initiation of DNA replication (G1
to S phase), at 12 h post infusion (Doetsch et al. 1999a).
In a separate study, after infusing the mice with AraC for
6 days, they injected BrdU 1 h before dissection and eval-
uated reappearance of proliferative cells in a course of
0–14 days after AraC removal and showed that BrdU-pos-
itive cells appeared 6–12 h after pump removal and were
scattered throughout the SVZ (Doetsch et al. 1999b).
Similarly, Pastrana e al showed that starting from a few
hours after removal of the antimitotic drug, the quiescent
NSCs activate for a short window of time to repopulate
depleted progeny in the niche (Pastrana et al. 2009). In
this study, we aimed to eliminate NSCs by their activation
via implementing Ara-C infusion gaps. Accordingly,
besides a short term (7 days) and a long term (14 days)
continuous Ara-C infusion, we also employed two other
kill paradigms for a total 14 days infusion with a 6 and
12 h drug infusion gaps on day 7. The success of the kill
paradigm were assessed by the neurosphere assay (NSA)
to compare the number of the remaining actively dividing
cells in different kill paradigms and the neural colony-
forming cell assay (N-CFCA) to ensure the presence or
absence of NSCs in the best kill paradigm.
Materials and Methods
Animals and experimental groups
Five-week-old male C57-BL6 mice were housed five per
cage and kept under a normal light–dark cycle (12 h light
and 12 h dark) in an air-conditioned room with a temper-
ature of 23  1°C in the animal facility of Shiraz Univer-
sity of Medical Sciences, with free access to food and
water. The Ethics Committee for Animal Experiments at
Shiraz University of Medical Sciences approved all animal
procedures that were performed based on the international
guidelines for biomedical research using animals. At the
beginning of the study, animals (N = 42) were randomly
divided into control, sham, and experimental groups. In
the control group, the animals were killed without any
intervention, their brains were removed and the right and
left SVZ were separately microdissected and cultured. In
the sham group, the animals received right intraventricular
infusion of 0.09% saline for 7 days before culturing their
SVZ. In the experimental groups, the animals received
right intraventricular infusion of 2% Ara-C for 7, 14, and
14 days with an infusion gap of 6 and 12 h on day 7 (7-
6 h-7 and 7-12 h-7 paradigms). Animals from the experi-
mental groups were killed immediately or 1 week after the
completion of Ara-C treatment. Animals from each group
were first anesthetized with isoflurane and then underwent
a cervical dislocation to harvest the brain tissue for culture
or perfused with cold 4% paraformaldehyde to preserve
the tissue for immunofluorescent analysis.
Osmotic mini-pump surgical implantation
Animals in sham and experimental groups were anes-
thetized by 4% isoflurane and subsequently secured in a
stereotaxic apparatus (Stoelting, Kiel, WI). While the ani-
mal head was positioned horizontally and the anesthesia
was maintained by 1.5–2% isoflurane via a facemask, eye
ointment was applied and scalp was shaved and cleaned
with alcohol and betadine. Then, a midline incision was
applied and the skin was retracted to expose the skull.
Using a sterile dental drill a 1 mm burr hole was made in
right side of the skull and the cannula of a brain kit 3
(Brain Infusion Kit, Durect, Cupertino, CA) was inserted
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into the right lateral ventricle and secured via Loctite 454
Cyanoacrylate Adhesive (Durect, Cupertino, CA) at the
following coordinate according to Paxinos mouse brain
Atlas: Anterior-Posterior (AP): 0. 2, Medial-Lateral
(ML): +0. 9 from the bregma point and Dorsal-Ventral:
+2.7 from the top of skull. The cannula was attached via
a connecting tube to an osmotic mini-pump (model
1007D; flow rate 0.5 L/h, 7 d; Durect) containing 100 lL
of sterile saline or 2% Ara-C solution. The pump reser-
voir was implanted under the skin on the back of the ani-
mal and was hydrated by subcutaneous injection of 1 mL
sterile saline to initiate pumping. Animals were given
Buprenorphine at 0.5 mg/kg every 12 h for 48 h to
reduce postoperative pain. In 14 days treatment groups
the empty pumps on day 7 were replaced with newly
filled pumping reservoirs immediately after removal of
the empty pump to ensure continuous Ara-C infusion or
6 and 12 h later to cause a 6 and 12 h gap in Ara-C infu-
sion in order to activate the dormant NSCs.
Neurosphere assay, sphere-forming
frequency and differentiation of neural
stem cells
A thin layer of tissue containing the SVZ of the lateral
ventricles, extending from the olfactory bulb to the cross-
ing of the anterior commissure, was carefully microdis-
sected from each brain and plated in neurosphere culture
as described elsewhere (Azari et al. 2010; Siebzehnrubl
et al. 2011). Briefly, tissue from the left and right SVZ
was removed separately and cut into very small pieces
and digested with 0.05% Trypsin-EDTA (Gibco, Carlsbad,
CA) for 5–7 min at 37°C. After enzymatic digestion, soy-
bean trypsin inhibitor (Sigma, St. Louis, MO) was added
and the cell suspension was mixed gently and centrifuged
at 110 g. The cell pellet was resuspended in neurocult-
neural stem cell (STEMCELL Technologies, Vancouver,
Canada) medium (500 lL) and mechanically dissociated
to achieve a single-cell suspension. The cell suspension
was spun (110 g, 5 min) to remove the supernatant.
Finally, the cells harvested from each SVZ were resus-
pended in complete neurosphere medium (5 mL) supple-
mented with EGF (20 ng/mL; STEMCELL Technologies),
bFGF (10 ng/mL; STEMCELL Technologies) and heparin
(2 lg/mL; Sigma, St. Louis, MO) and incubated in a T25
flask (NUNC) in a humidified incubator with 5% CO2
for 8 days. The number of neurospheres were counted
and compared between different treatment groups. To
evaluate the capability of the resulting neurospheres for
long-term passage, the neurospheres were first dissociated
into single cells and replated in complete neurosphere
medium supplemented with growth factors for 8 days.
Every 8 days the spheres were harvested and replated in
fresh medium and the total number of harvested cells was
recorded per each passage. To evaluate the differentiation
capabilities of the neurospheres, single cell harvested from
dissociated neurospheres were plated in neuroblast assay
differentiation culture (Azari et al. 2012) for 8 days and
immunostained for neuronal marker ß-III tubulin and
glial marker glial fibrillary acidic protein (GFAP).
Neural colony-forming cell assay and stem
cell frequency
The harvested SVZ tissue from each brain of the selected
groups (control animals and animals treated with 7-6 h-7
Ara-C kill paradigm) was processed in the same way as
described for neurosphere assay and finally cultured in a
semisolid collagen-based medium known as the neural
colony-forming cell assay (N-CFCA, STEMCELL Tech-
nologies, Vancouver, Canada) for 28 days to discriminate
stem cells (colonies equal or bigger than 2 mm in diame-
ter) from the progenitor cells (colonies less than 2 mm)
based on their proliferative potential (Louis et al. 2008;
Azari et al. 2011). Culture plates were fed every week with
medium supplemented with EGF and b-FGF as per man-
ufacturer’s instruction. After 28 days, colonies were
counted and their size was measured.
Immunofluorescence staining
Control animals and animals treated with 7-6 h-7 Ara-C
kill paradigm were first anesthetized by 4% isoflurane and
then perfused transcardially with 0.09% saline and 4%
cold paraformaldehyde in PBS (pH= 7.4). Brains were
postfixed by immersion in the same fixative overnight and
then immersed in 30% sucrose solution for 2 days. Serial
10 lm cryosections were prepared form the SVZ of lateral
ventricles for immunofluorescence staining. Immunofluo-
rescence staining was performed using the standard proto-
col by overnight incubation of samples in right
combination of rabbit anti-GFAP (DakoCytomation), gui-
nea pig anti-DCX (Millipore), rabbit anti-ki67 (Millipore)
and mouse anti-Nestin (Millipore, MAB353) primary anti-
bodies in 0.03% PBS-Triton-9100 supplemented with 5%
normal goat serum. After three washing with PBS, the pri-
mary antibodies were detected by incubation of samples
for 1 h at room temperature in 0.03% PBS-Triton-9100
supplemented with 5% normal goat serum containing sec-
ondary antibodies conjugated with Alexa flour 488 and
568 and DAPI for nuclear staining. Seven representative
sections with an approximately 350 micron interval from
the entire SVZ extending from anterior commissure to the
beginning of the olfactory bulb were carefully monitored
for each staining and the number of immunostained cells
was quantified in each section. Then, an average number/
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section was calculated for each animal. Data from three
animals/group were presented here as mean  SEM. Rep-
resentative images for each staining were also captured
using a fluorescent microscope (Nikon Eclipse E600, Fall
River, MA) and the images were merged using Adobe Pho-
toshop CS4 software.
Statistics analysis
Data analysis was performed using one-way ANOVA or
Student’s t-tests as appropriate (Prism 5; Graphpad Soft-
ware Inc., San Diego, CA). Results were expressed as
mean  SEM and the level of significance was set at a P-
value of less than 0.05.
Results
Intraventricular Ara-C infusion depletes
dividing cells in the subventricular zone
To evaluate the efficiency of different kill paradigms in
depleting dividing cells in the subventricular zone (SVZ)
of the lateral wall of the lateral ventricles in adult mouse
brain, we employed the neurosphere assay (NSA), which
is routinely used as a valid in vitro readout of the overall
neural stem and progenitor cells number in a given part
of the nervous tissue (Azari et al. 2010; Siebzehnrubl
et al. 2011) (Fig. 1A). All values are presented as a per-
centage of their corresponding control values. Moreover,
the mean absolute neurosphere number per each condi-
tion is shown in Table 1. Comparing control- and sham-
treated groups revealed that 1 week of continuous saline
infusion did not significantly decrease the mean neuro-
sphere-forming frequency (NFF) in harvested cells from
the right, left, and combined SVZs, respectively
(85.29  2.6% vs. 100  8.8% in Rt SVZ,
88.96  2.91% vs. 100  9.7% in Lt SVZ and
92  5.64% vs. 100  9.7% in combined SVZs in saline
vs. control group, respectively, Fig. 1B).
In experimental groups, the mean NFF of the harvested
cells from right, left, and combined SVZs significantly
decreased in all kill paradigms immediately after comple-
tion of Ara-C treatment comparing to the control
(5.6  2.4%, 2.8  1.1%, 1.3  0.5%, 0.56  0.32% in
Rt SVZ; 5  1.1%, 2.7  0.2%, 1.46  0.2%,
1.67  0.32% in Lt SVZ; 5.3  1.56%, 2.75  0.55%,
1.37  0.19%, 1.1  0.2% in combined SVZs in 7, 14,
7-6 h7, 7-12 h-7 days infusion paradigms, respectively).
All these values were significantly different to the control
(Fig. 1C, P < 0.0001). Moreover, comparing different
Ara-C treatment paradigms revealed that neurosphere
reduction was significantly higher in Lt SVZ of 14 days,
7-6 h-7, and 7-12 h-7 paradigms and in combined SVZs
of 7-6 h-7 and 7-12 h-7 paradigms comparing to 7 days
paradigm (Fig. 1C, P < 0.05).
Morphological assessment showed that neurospheres
resulted from the control and sham groups were big,
round, and not compact (Fig. 2A, B). In contrast, neuro-
spheres in Ara-C-treated groups appeared small, compact
and sometimes irregular-shaped (Fig. 2C–F). To evaluate
whether these neurospheres were derived from NSCs or
progenitor cells, we collected all the resulting neuro-
spheres from the control, sham and Ara-C kill paradigms,
dissociated them into single cells and replated in neuro-
sphere culture to assess their ability for long-term passag-
ing. Interestingly, except for the control and sham group,
the cells from all Ara-C groups failed to expand beyond
1–2 passages in vitro.
Resulting neurospheres from the control group
expressed glial fibrillay acidic protein (GFAP) and nestin
as neural stem and progenitor cell markers and generated
neuronal and glial cells upon differentiation as evidenced
by expression of ß-III tubulin, GFAP, and myelin basic
protein (MBP) (Fig. 2L, M).
The NSC niche of the SVZ repopulates
1 week after completion of intraventricular
Ara-C infusion
To test which Ara-C kill paradigm has a longer lasting
effects in terms of neural stem and progenitor cell reduc-
tion, we prepared a second set of animals with the same
Figure 1. Study design, neurosphere assay and comparing the number of neurospheres in different Ara-C kill paradigms (A–D). A: Schematic
diagram showing the study design and the neurosphere assay. B: Relative number of neurospheres per right, left and combined subventricular
zone (SVZ) tissue in control and sham (saline infused) groups. No statistically significant difference was observed. C: Relative number of
neurospheres per right, left and combined SVZ tissue in control versus different Ara-C kill paradigms immediately after completion of Ara-C
infusion. As evident, neurosphere formations reduced significantly in all Ara-C kill paradigms comparing to the control group (***P < 0.0001).
This reduction was significantly higher in 14 days, 7-6 h-7, and 7-12 h-7 infusion paradigms (**P < 0.001, *P < 0.05) comparing to 7 days
infusion paradigm. D: Relative number of neurospheres per right, left, and combined SVZ tissue in control versus different Ara-C kill paradigms
1 week after completion of Ara-C infusion. Interestingly, neurosphere formation frequency increased to 10–30% of control value but still is
significantly lower in all Ara-C groups comparing to the control group (***P < 0.0001). 14 days, 7-6 h-7, and 7-12 h-7 infusion paradigms
resulted in a more pronounced reduction (***P < 0.0001, **P < 0.001, *P < 0.05) as compared to the 7 days infusion paradigm. All values are
mean  SEM relative to control. N = 3 independent experiments.
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Ara-C kill paradigms as described before and let them
survive for a week after completion of Ara-C infusion
before culturing them in neurosphere assay (NSA).
Although the mean NFF of all Ara-C treatment groups
increased (varying from 10 to 30% of the matched con-
trol groups), these values were still significantly lower
comparing to their corresponding control groups
(28.12  0.67%, 26.1  1.34%, 11.73  4.8%,
12.85  2.88% in Rt SVZ; 35.83  1.16%%,
28.96  0.91%, 15.63  0.95%, 16.46  0.75% in Lt
SVZ; 31.76  0.8%, 27.43  0.95%, 13.57  2.86%,
14.55  1.82% in combined SVZs in 7, 14, 7-6 h-7,
7-12 h-7 days infusion paradigms, respectively, Fig. 1D,
P < 0.0001). Mean absolute neurosphere number per each
condition is shown in Table 1.
Moreover, statistical analysis between different Ara-C
treatment groups at 1 week after completion of Ara-C
infusion revealed that mean NFF was significantly lower
in Rt SVZ of 7-6 h-7 and 7-12 h-7 paradigms comparing
to 7 and 14 days paradigms (Fig. 1D, P < 0.05) and in Lt
SVZ of 14 days, 7-6 h-7, and 7-12 h-7 paradigms com-
paring to 7 days paradigm and also 7-6 h-7 and 7-12 h-7
paradigms comparing to 14 days paradigm (Fig. 1D,
P < 0.0001). Similarly, these values were also significantly
lower in combined SVZs of 7-6 h-7 and 7-12 h-7 para-
digms comparing to 14 and 7 days paradigm (Fig. 1D,
P < 0.0001, P < 0.05, respectively).
Morphologically, neurospheres resulted from Ara-C-
treated groups 1 week after completion of Ara-C infusion
(Fig. 2G–J) were more similar to the control and sham
(Fig. 2A, B) in terms of their size, shape and compact-
ness. Serial passaging of these neurospheres showed that
all Ara-C groups could successfully expand in vitro at a
comparable level to the neurospheres from control and
sham groups (Fig. 2K). Resulting neurospheres from the
Ara-C groups expressed glial fibrillay acidic protein
(GFAP) and nestin as neural stem and progenitor cell
markers and generated neuronal and glial cells upon dif-
ferentiation as evidenced by expression of ß-III tubulin,
GFAP, and MBP (Fig. 2L, M).
Neural stem cells (NSCs) escape Ara-C kill or
re-emerge from a developmentally more
primitive cell source even in the most
rigorous Ara-C kill paradigm
One week after completion of Ara-C infusion the mean
NFF increased in all kill paradigms and reached to
10–30% of the control value. This implies reactivation of
NSCs in niches after AraC removal and generation of new
proliferating progeny that resulted in more neurosphere
formation upon culture. To confirm the presence of NSCs
in the harvested SVZs of the adult mouse brain afterT
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Figure 2. Representative neurosphere pictures from different treatment groups, serial passaging and immunostaining of neurospheres and
differentiated neural stem cells (A–M). A, B: Neurospheres grown after 8 days in culture from the SVZ tissue harvested from control and sham
groups, respectively. No differences could be noticed in their relative size and morphology. C-F: Neurospheres grown after 8 days in culture from
the SVZ of animals harvested immediately after completion of Ara-C treatments from different Ara-C kill paradigms. As evident, neurospheres are
smaller in size and appear more compact comparing to the control group. G–J: Neurospheres grown after 8 days in culture from the SVZ of
animals harvested 1 week after completion of Ara-C treatments from different Ara-C kill paradigms. As shown, neurospheres are more similar to
the control group but still are smaller in size. K: Neurospheres harvested from control, sham, and all Ara-C treatment groups that were harvested
1 week after completion of Ara-C treatment could be serially passaged in culture (N = 3 independent experiments for each condition). L:
Representative neurospheres from the control and different Ara-C kill paradigms 7 days after completion of Ara-C infusion. Neurospheres were
immunostained for GFAP, Nestin and counterstained with DAPI. M: Representative immunostaining for neuronal (ß-III tubulin), astrocytic (glial
fibrillary acidic protein, GFAP) and oligodendroglial (myelin basic protein, MBP) differentiation of the harvested neural stem cells from the control
and 7-6 h-7 Ara-C kill paradigm 7 days after completion of Ara-C infusion. Scale bars represent 100 lm in neurosphere pictures and 50 lm in
differentiated NSCs pictures.
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Ara-C treatment, we employed the neural colony-forming
cell assay (N-CFCA) that can detect these cells based on
their long-term proliferation capabilities (Louis et al.
2008; Azari et al. 2011). We harvested SVZ tissue from
the animals treated with 7-6 h-7 Ara-C kill paradigm and
compared its stem cell frequency with an untreated con-
trol group. 7-6 h-7 Ara-C kill paradigm was chosen as it
appeared as one of the most efficacious paradigm in
terms of reducing neurosphere formation in animals
killed immediately and 1 week after Ara-C treatment
completion with no statistically significant difference to
7-12 h-7 Ara-C kill paradigm. After 28 days of culturing
the harvested SVZs cells in a semisolid collagen-based
medium, the total number of colonies (representing the
number of stem and progenitor cells collectively) and also
colonies equal or bigger than 2 mm in diameter (repre-
senting the number of NSCs) were quantified for each
group (Fig. 3A–D). While the total number of colonies
was 350  21.67 per combined SVZs in control group,
this measure was 5.5  1.26 (1.57  0.36% of the con-
trol) and 37.33  3.28 (10.66  0.94% of the control) in
7-6 h-7 Ara-C kill paradigm immediately and 1 week
after completion of Ara-C treatment, respectively
(Fig. 3 E). Statistical analysis showed that the number of
colonies was significantly lower in Ara-C-treated groups
compared to the control group (P < 0.0001).
While the number of NSC-derived colonies per com-
bined SVZs was 4  1.15 (1.14  0.32% of the total
colonies) in control group, we could not found any NSC-
derived colonies (colonies equal or bigger than 2 mm in
diameter) in 7-6 h-7 Ara-C kill paradigm immediately
and 1 week after completion of Ara-C treatment, respec-
tively (Fig. 3F). Furthermore, while in 7-6h-7 Ara-C kill
paradigm immediately after completion of Ara-C treat-
ment the majority of colonies were less than 1 mm in
diameter, we could find a few colonies between
1–1.5 mm (28.6  2.4% of total colonies) and one col-
ony between 1.5–2 mm (0.9  0.9% of total colonies)
1 week after completion of Ara-C treatment. Although we
could not find NSC-derived colonies, choosing 19 colo-
nies close to 1.5 mm in diameter showed that four of
them (including the colony with the diameter between
1.5–2 mm) could be serially passaged implying the pres-
ence of NSCs in those colonies (data not shown).
Immunofluorescent analysis of the Ara-C-
treated SVZ immediately after completion
of 7-6 h-7 Ara-C kill paradigm
To evaluate the effectiveness of 7-6 h-7 Ara-C kill para-
digm in depletion of stem and progenitor cells and assess
the cellular composition of the SVZ immediately after
completion of Ara-C treatment, we immunostained
representative sections from the control as well as the
Ara-C-treated animals with different markers such as
GFAP and nestin (NSC markers), doublecortin (DCX, a
marker of neuroblast cells), and Ki-67 (a marker of
actively dividing cells). Close assessment of the SVZ
region in the lateral wall of the lateral ventricle extending
from the level of anterior commissure to the olfactory
bulb under a fluorescent microscope showed that GFAP
(A) (B)
(C)
(E) (F)
(D)
Figure 3. Representative colonies grown in N-CFCA and the colony-
forming frequency in control and 7-6 h-7 Ara-C kill paradigm animals
immediately and 1 week after completion of Ara-C infusion (A–F). A–
D: Representative colonies are shown at different size categories; A:
less than 0.5 mm in diameter, B: 0.5–1 mm, C: 1–2 mm, and D:
equal or bigger than 2 mm in diameter. A, B, and C are progenitor-
derived colonies and D is a NSC-derived colony. E: Colony-forming
frequency per brain (combined Rt & Lt SVZs) in control and 7-6 h-7
Ara-C kill paradigm immediately and 7 days after completion of Ara-
C treatment. The overall number of colony was significantly higher in
the control group (***P < 0.0001). F: Frequency of NSC-derived
colonies (equal or bigger than 2 mm in diameter) as a percentage of
total colonies in control and 7-6 h-7 Ara-C kill paradigm immediately
and 7 days after completion of Ara-C treatment. No colonies of equal
or bigger than 2 mm were grown from SVZ N-CFCA culture in 7-6 h-
7 Ara-C kill paradigm. Scale bars represent 500 lm in colony pictures.
All values are mean  SEM. N = 3 independent experiments.
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staining was present in both the control and Ara-C-trea-
ted animals. Interestingly, while this staining was very
intense in control group and the cells could be observed
in both the SVZ and surrounding regions with detectable
cell bodies and processes, in Ara-C-treated group the
GFAP staining was mainly found in the neighboring stria-
tum while extending some processes toward the SVZ
(Fig. 4A, B). We could count an average of 6.43  0.93
GFAP-positive cells/section in the SVZ of the animals
killed immediately after 7-6 h-7 Ara-C kill paradigm,
whereas this number was 29.43  4.53 in control ani-
mals. Furthermore, DCX positive neuroblast cells were
only found in the control animals in patches surrounded
by the GFAP-positive cells (24.95  4.29 cells/section,
(A)
(B)
(C) (D)
(E) (F)
Figure 4. Representative immunofluorescent images from the subventricular zone (SVZ) of control and Ara-C treated (7-6 h-7 Ara-C kill
paradigm) animals immediately after completion of Ara-C infusion (A–E). All sections are counterstained with DAPI (blue) to visualize the nuclei.
A, B: GFAP (red) and doublecortin (DCX, green) stained sections from the SVZ of control (A) and Ara-C (B) groups. GFAP staining could be
observed in both groups. These cells and their processes (arrow heads) could sharply be detected in both ad-luminal (immediately under the lining
of the ventricle) and ab-luminal (close to striatal parenchyma) parts of the SVZ in control group. DCX staining was limited to the control group
and could be visualized as clusters of cells (arrows) surrounded by GFAP-stained cell processes. C, D: Nestin immunostaining of representative
sections from the SVZ of control (C) and Ara-C (D) groups. As evident, nestin staining could be observed as layers of intense green-stained cells
(arrow heads) lining the lateral wall of the ventricle in control group. This staining was mainly lost in the Ara-C treatment group and only a faint
trace of nestin immunoreactivity could be detected in the lining of the lateral ventricle. E, F: Ki-67 immunostaining of control (E) and Ara-C (F)
treated SVZs. While many Ki-67 immunoreactive proliferative cells (arrows) were detected either as clusters or individual cells in control SVZ, these
cells were almost depleted from the Ara-C treated SVZs. LV: Lateral Ventricle, S: Striatum. Scale bar represents 50 lm.
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Fig. 4A, B). Similarly, nestin (21.24  2.31 cells/section,
Fig. 4C, D) and Ki-67 (30.62  18.78 cells/section
Fig. 4E, F) immunoreactive cells were abundant in the
SVZ of the control animals while a faint trace of nestin
were detected mainly in ventricular lining of the lateral
wall of the lateral ventricle and very few Ki-67 immunore-
active cells could be observed in the SVZ region in 7-6 h-
7 Ara-C treatment group (0.19  0.12 cells/section).
Overall, immunofluorescent analysis demonstrated that
intermittent Ara-C treatment as applied in 7-6 h-7 Ara-C
kill paradigm could effectively deplete most of the neural
stem and progenitor cells from the SVZ of the adult
mouse brain.
Discussion
We aimed to investigate the effects of intermittent Ara-C
infusion into the lateral ventricles of the adult mouse
brain eliminating the entire NSCs population from the
subventricular zone. Knowing that NSCs are usually in a
dormant or quiescent status and divide only to maintain
themselves and to repopulate the lost progeny in their
niches, we took advantage of this notion to eliminate
NSCs by recruiting them after depletion of their immedi-
ate progeny using the antimitotic drug Ara-C. Our results
demonstrated that by introducing a gap of 6 or 12 h in a
14 day Ara-C kill paradigm, the number of NSCs would
significantly decrease comparing to the 7 and 14 days
continuous Ara-C kill paradigms. Importantly despite sev-
ere reduction in stem and progenitor cells in all kill para-
digms, none of the kill paradigms resulted in permanent
depletion of NSCs and the SVZ niches repopulate via the
escaped NSCs or from a more undifferentiated precursor
cells in their developmental hierarchy.
Ara-C infusion for 7, 14, and 14 days with 6 or 12 h of
infusion gaps eliminated around 95%, 97%, 98%, and
99% of actively dividing cells from the subventricular
zone of the lateral ventricle, respectively. Although these
numbers seems to be very close, the small differences in
percentages reflects the success of different kill paradigms
in depletion of NSCs. Accordingly, the 7-6 h-7 and
7-12 h-7 kill paradigms turned out to be much more
effective in elimination of NSCs than the 7 and 14 day
continuous Ara-C infusion. This is further evidenced by
the statistically significant differences observed in neuro-
sphere formation recovery rate 7 days post Ara-C treat-
ment in different kill paradigms (Fig. 1D). While the 7
and 14 days continuous Ara-C infusion paradigms
reached to almost 30% neurosphere-forming frequency of
the control group 7 days post Ara-C infusion, the 7-6 h-7
and 7-12 h-7 paradigms could only reach to less than
15% of this value. This delay in neurosphere formation
recovery in 7-6 h-7 and 7-12 h-7 kill paradigms is simply
due to loss of a fair number of NSCs upon recruiting into
the pool of actively dividing cells and subsequent deple-
tion via re-exposure to Ara-C. Therefore, although the
length of Ara-C infusion is important to efficiently kill
the stem and progenitor cells, for example, as evident in
14 days comparing to 7 days continuous Ara-C infusion
paradigm, the infusion gaps play a more important role
as comparing the 7-6 h-7 and 7-12 h-7 to 14 days para-
digms. Our results are in agreement with the study by
Morshead at al., (Morshead et al. 1994) in which they
showed that double kill paradigm using 3H-Thymidine on
day 0 and day 2 resulted in a 50% reduction in NSCs
population that did not return to the control values even
after 31 days post kill. Despite differences in the antimi-
totic agents (Ara-C vs. 3H-Thymidine) and time-line of
re-exposure (2 days vs. 6 or 12 h after the initial expo-
sure) in these two studies, we achieved similar results.
This implies that at a given time point after the initial
exposure not more than 50% of the dormant NSCs popu-
lation become activated and hence not all NSCs could be
eliminated using this double kill paradigms.
Long-term proliferation or the ability to generate a
large number of progeny is one of the cardinal features of
NSCs upon which they could be distinguished from the
other progenitor cells in a given neural cell population.
Hence, neurospheres generated from stem cells are cap-
able of generating new spheres upon replating and this
can continue indefinitely (Reynolds and Weiss 1992;
Deleyrolle et al. 2011). Interestingly, the neurospheres
resulted from all kill paradigms in animals killed immedi-
ately after completion of Ara-C infusion could not be
serially passaged but neurospheres resulted from the ani-
mals killed 7 days after completion of Ara-C infusion
could be passaged several times and generate a large num-
ber of progeny in all Ara-C kill paradigms (Fig. 2K). The
inability to serially passage neurospheres resulted from
the SVZs harvested immediately after Ara-C infusion
could be justified in two possible scenarios. First, long-
term exposure to Ara-C could temporarily inactivate the
cell cycle machinery of the remaining NSCs, hence, cul-
turing the SVZ cells immediately after Ara-C exposure in
a proliferative condition may not result in generation of
actively proliferative progeny to ensure serial passaging.
This is evidenced by formation of very few small, com-
pact and irregular-shaped neurospheres in all Ara-C-trea-
ted groups (Fig. 2C-F). These cells might need
interactions with other cells in their in situ niches to
receive appropriate signals in order to get reactivated and
become fully functional. Support for this statement comes
from the capability of the neurospheres from the cells
harvested 7 days after completion of Ara-C infusion from
the SVZ of all kill paradigms. Second, long-term exposure
to Ara-C could wipe out the majority of NSCs. In a study
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by Louis et al., (Louis et al. 2008), while developing the
N-CFCA, they found that 1 day infusion of 2% Ara-C
into the lateral ventricle resulted in a sharp decrease in
progenitor-derived colonies but not in stem cell–derived
colonies. Increasing the Ara-C infusion to three
consecutive days resulted in a significant decrease in stem
cell–derived colonies. Considering this study, we infused
Ara-C twice as long in the shortest kill paradigm, it is
logical to expect a substantial loss of NSCs at least in
7-6 h-7 and 7-12 h-7 paradigms. The justification for
acquiring long-term passage capability of the resulting
neurospheres 7 day after completion of Ara-C could be
due to acquiring full proliferative potential recovery of
the remaining NSCs or emergence of new NSCs from a
more undifferentiated precursor cells residing in the SVZ.
In support of the latter hypothesis, it has recently been
shown that after complete ablation of GFAP expressing
type B adult NSCs in GFAP-thymidine kinase transgenic
mice (GFAP-TK) using Ganciclovir (GCV), type B adult
NSCs could be replenished from a very rare population
of leukemia inhibitory factor (LIF) responsive primitive
neural stem cells (pNSCs) (Sachewsky et al. 2014).
In line with our NSA results, immunofluorescent analy-
sis on the SVZ of 7-6 h-7-paradigm immediately after
completion of Ara-C infusion showed that all dou-
blecortin-positive type A cells and almost all of the
actively proliferating Ki-67-positive cells and also nestin
immunoreactive cells were depleted, whereas some GFAP-
positive cells were still present in the subventricular areas
of the lateral ventricles. Of these GFAP-positive cells a
very small fraction could be dormant stem cells but it is
very difficult and inaccurate to quantify the number of
remaining NSCs based of GFAP immunoreactivity due to
presence of other GFAP expressing astrocytes in subven-
tricular zone. To circumvent this limitation, we per-
formed N-CFCA to ensure the presence or absence of
these cells based on their functional criteria in generating
large colonies as mentioned earlier. N-CFCA of the cells
harvested from the SVZ of the 7-6 h-7-kill paradigm
immediately after completion of Ara-C infusion resulted
in formation of very few small colonies that apparently
were not derived from NSCs. On the basis of serial pas-
saging capability of the neurospheres resulted from cells
harvested from the SVZ of 7-6 h-7-paradigm 7 days after
completion of Ara-C infusion, we expected to see large
NSC-derived colonies upon plating cells from this group.
Surprisingly, although the number and size of colonies
increased, we could find some relatively large colonies
(between 1-1.5 mm in diameter) that could serially prop-
agate in vitro indicating the presence of NSCs in these
colonies. This phenomenon could either be because of
defective proliferation of the remaining NSCs due to
long-term Ara-C exposure or is an indication for presence
of new NSCs from the source of pNSCs. The latter might
acquire more of adult NSC characteristics upon culturing
and passaging in vitro to generate large number of pro-
geny.
Conclusions
This study clearly showed that implementing Ara-C
infusion gaps is very necessary to effectively eliminate
NSCs through their recruitment into the actively divid-
ing cell pool. Using this strategy, we could eliminate a
fair number of the NSCs but it should be emphasized
that this effect is temporary and the stem cell niches in
subventricular zone of the adult mouse brain repopulate
via the remaining NSCs or through a more undifferen-
tiated precursor cells in their developmental hierarchy.
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